UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000036106
Receipt number R000041111
Scientific Title Verification of Hand Antisepsis and Its Feeling.
Date of disclosure of the study information 2019/03/13
Last modified on 2019/09/04 12:16:35

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Verification of Hand Antisepsis and Its Feeling.

Acronym

Verification of Hand Antisepsis and Its Feeling.

Scientific Title

Verification of Hand Antisepsis and Its Feeling.

Scientific Title:Acronym

Verification of Hand Antisepsis and Its Feeling.

Region

Japan


Condition

Condition

N/A (healthy adults)

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

This study aims to verify of hand antisepsis and its feeling.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

[1]Feeling questionnaire (1st time and 10th time after application).

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Non-randomized

Randomization unit


Blinding

Single blind -participants are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

4

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

Application of test product (10 times).

Interventions/Control_2

Application of control product A (10 times).

Interventions/Control_3

Application of control product B (10 times).

Interventions/Control_4

Application of control product C (10 times).

Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

22 years-old <=

Age-upper limit

60 years-old >

Gender

Female

Key inclusion criteria

[1]Males or females aged 22-59 years.
[2]Nurse and laboratory technician who works at a hospital with an Infection Control Committee and an Infection Control Nurse.
[3]Nurse and laboratory technician who uses hand antisepsis daily.
[4]Nurse and laboratory technician whose written informed consent has been obtained.
[5]Nurse and laboratory technician who can have an examination in a designated day.
[6]Nurse and laboratory technician judged appropriate for the study by the principal.

Key exclusion criteria

[1]Individuals using medical products.
[2]Individuals with strange skin conditions at measurement points.
[3]Individuals with a scar, an inflammation, eczema, and sunburn on measurement points (inside of the palm).
[4]Individuals who are sensitive to alcohol.
[5]Individuals with probable skin disease such as itching, rubefaction, and eczema.
[6]Individuals who are or are possibly, or are lactating.
[7]Individuals judged inappropriate for the study by the principal.

Target sample size

12


Research contact person

Name of lead principal investigator

1st name Takahiro
Middle name
Last name Ono

Organization

Ueno-Asagao Clinic

Division name

Head

Zip code

110-0015

Address

6F Kairaku Building 2-7-5 Higashiueno Taito-ku Tokyo 110-0015, JAPAN

TEL

+81-3-6240-1162

Email

info@ueno-asagao.clinc


Public contact

Name of contact person

1st name Ryoma
Middle name
Last name Shimizu

Organization

TES Holdings Co., Ltd.

Division name

Administrative Department of Clinical Trials

Zip code

110-0015

Address

6F Kairaku Building 2-7-5 Higashiueno Taito-ku Tokyo 110-0015, JAPAN

TEL

+81-3-6801-8480

Homepage URL


Email

r.shimizu@tes-h.co.jp


Sponsor or person

Institute

TES Holdings Co., Ltd.

Institute

Department

Personal name



Funding Source

Organization

GOJO Japan, Inc.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ueno-Asagao Clinic Ethical Review Committee

Address

6F Kairaku Building 2-7-5 Higashiueno Taito-ku Tokyo 110-0015, JAPAN

Tel

+81-3-6240-1162

Email

jimukyoku@tes-h.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 03 Month 13 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2019 Year 03 Month 06 Day

Date of IRB

2019 Year 03 Month 07 Day

Anticipated trial start date

2019 Year 03 Month 24 Day

Last follow-up date

2019 Year 03 Month 24 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2019 Year 03 Month 06 Day

Last modified on

2019 Year 09 Month 04 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000041111


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name